NCT06993506 2025-05-29
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
New Mexico Cancer Research Alliance